Sutro Biopharma
Latest round
- Series E
Last raised
- Aug 2018
Total raised
- $181M
Investors
- 14
About Sutro Biopharma
Sutro Biopharma, Inc.Founded in 2003 and headquartered in South San Francisco, US, Sutro Biopharma, Inc. specializes in cancer therapeutics.00 mn in December 2020. The company has executed 12 deals, with its most recent deal occurring on September 26, 2018.Sutro Biopharma, Inc. specializes in the discovery and development of innovative cancer therapeutics, primarily focusing on site-specific antibody-drug conjugates (ADCs) and other advanced biologics. The proprietary XpressCF® system enables rapid production of these therapeutics, targeting various cancers with high precision to enhance patient outcomes while minimizing off-target effects.24 mn. Revenue is derived through collaborative partnerships and licensing agreements with pharmaceutical companies for the development of proprietary therapeutics, involving upfront payments, milestone payments, and royalty payments on future sales.00 mn, to advance the development of new products and expand into new markets. The company is working on innovative ADCs set for launch in upcoming quarters. Sutro aims to penetrate additional European markets and increase its presence in Asia by 2025.
Who invested in Sutro Biopharma
14 investors across 8 rounds
See all investors in Sutro Biopharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series E
Aug 8, 2018
Amount
$54M
Investors
Series E
May 24, 2018
Amount
$32M
Investors
Series D
Dec 11, 2013
Amount
$26M
Investors
Series C
Mar 28, 2012
Amount
$13M
Investors
Series C
Nov 5, 2010
Amount
$19M
Investors
Series B
Mar 30, 2009
Amount
$15M
Investors
Series B
Dec 10, 2007
Amount
$21M
Investors
Series A
Jun 1, 2006
Amount
$1M
Investors
Questions about Sutro Biopharma
Who invested in Sutro Biopharma?
Sutro Biopharma has 14 investors on record across 8 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sutro Biopharma raised?
Sutro Biopharma has raised 8 venture rounds. Sign up free to see how much each round raised and the total.
When did Sutro Biopharma last raise money?
Sutro Biopharma's most recent round on record is a Series E, in Aug 2018.
What does Sutro Biopharma do?
Sutro Biopharma is a biotechnology company.
Where is Sutro Biopharma headquartered?
Sutro Biopharma is headquartered in South San Francisco, US.
Which VCs invest in companies like Sutro Biopharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Sutro Biopharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like Sutro Biopharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.